Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy

NCT ID: NCT03160690

Last Updated: 2017-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-17

Study Completion Date

2018-05-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective and observational study to determine if choroidal thickness increases after non penetrating deep sclerectomy in patients with open angle glaucoma

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Choroidal Thickness Open Angle Glaucoma Non Penetrating Deep Sclerectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non penetrating deep sclerectomy

Non penetrating deep sclerectomy for open angle glaucoma

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Progressive Primary Open Angle Glaucoma

Exclusion Criteria

* Age under 18yrs
* Myopia or Hyperopia higher than -6D or +6D
* Secondary glaucoma
* Ocular surgery other than cataract
* Other ocular pathology
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pau Romera Romero

UNKNOWN

Sponsor Role collaborator

Jorge Loscos Arenas

UNKNOWN

Sponsor Role collaborator

Nevena Romanic Bubalo

UNKNOWN

Sponsor Role collaborator

Jordi Castellví Manent

UNKNOWN

Sponsor Role collaborator

Germans Trias i Pujol Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sandra Gómez Sánchez

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sandra Gómez Sánchez, MD

Role: PRINCIPAL_INVESTIGATOR

Germans Trias i Pujol Hospital

Pau Romera Romero, MD

Role: PRINCIPAL_INVESTIGATOR

Germans Trias i Pujol Hospital

Jorge Loscos Arenas, PhD

Role: PRINCIPAL_INVESTIGATOR

Germans Trias i Pujol Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Germans Trias i Pujol Hospital

Badalona, Barcelona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sandra Gómez Sánchez, MD

Role: CONTACT

0034934978919

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sandra Gómez Sánchez, MD

Role: primary

0034934978919

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OFT-ENP-2017-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.